Additional information
| Active substance | Metformin, Pioglitazone |
|---|---|
| Water Retention | Moderate (Pioglitazone) |
| Hepatotoxicity | Low risk, but monitoring is advised |
| Lab Test | Monitoring of liver function tests, kidney function tests, and blood glucose levels |
| Strength | 15/500mg |
| Also known as | Pioglitazone/Metformin combination |
| Blood pressure | Can potentially lower blood pressure |
| Trade name | Actoplus Met |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | Pioglitazone Hydrochloride, Metformin Hydrochloride |
| Formula | Pioglitazone: C19H20N2O3S В· HCl |
| Substance class | Thiazolidinedione (Pioglitazone), Biguanide (Metformin) |
| Main action | Antidiabetic |
| Half-life | Pioglitazone: 3-7 hours |
| Dosage (medical) | Typically 15-30 mg of Pioglitazone combined with 500-2000 mg of Metformin daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces insulin resistance, decreases glucose production in the liver |
| Side effects | Weight gain, edema, risk of heart failure (Pioglitazone), gastrointestinal disturbances, lactic acidosis (Metformin) |
| Use in sports | Not typically used |
| Manufacturer | USV Pvt. Ltd. |
| Packing | 10 tabs/blister |
Champix 56 tabs Pfizer
Rovamycine 3.000.000 iu Eczacibasi
Avory Pharma Oral Turinabol 10 mg 100 Kapseln
Prograf 1mg Astellas Pharma
FUCIDIN 500 mg Abdi Ibragim
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Januvia 100mg Merckgroup
Clenbolic Clenbuterol Hydrochlorid Cooper Pharma
SoPharma Clenbuterol 0,2 mcg 50 Tabletten
SIBUTROS Pharmacom
Norvacs 10 mg Pfizer 




Reviews
There are no reviews yet.